当前位置:首页 > 清远分析 > 正文内容

Ripple Therapeutics宣布与艾伯维公司达成合作和许可选择协议,共同开发下一代青光眼治疗方案

admin10个月前 (09-22)清远分析711

- Collaboration to leverage AbbVie's eye care expertise and Ripple's innovative drug delivery platform to develop next-generation sustained release drug delivery implants for the treatment of glaucoma

TORONTO, ON / ACCESSWIRE / September 17, 2024 / Ripple Therapeutics today announced a collaboration and option-to-license agreement with AbbVie to develop RTC-620, a next generation, fully biodegradable, sustained release drug delivery intracameral implant with repeat dosing capabilities to reduce intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). This collaboration leverages AbbVie's expertise in eye care and Ripple's innovative drug delivery platform.

Ripple's patented technology platform is based on a discovery that drugs can be engineered into controlled release pharmaceuticals without the use of polymers or excipients. These proprietary prodrugs undergo surface erosion to give zero order release kinetics and are highly customizable to tailor both drug dose and duration. Because there are no polymers or excipients, once the drug is gone, the implant is gone with no pro-inflammatory degradation products, which supports repeat dosing.

"We're pleased to partner with AbbVie, a worldwide leader in ophthalmic therapeutics," said Tom Reeves, President and Chief Executive Officer, Ripple Therapeutics. "By combining our drug delivery platform with AbbVie's research, clinical, regulatory and commercial capabilities, we hope to deliver a meaningful impact on the lives of people living with glaucoma."

Millions of people are living with glaucoma, one of the leading causes of vision loss. New treatment options are needed to help patients challenged with topical drops or who are at risk for vision loss and looking for alternative treatment options.

"At AbbVie, we strive to find innovative solutions to build our portfolio of vision-preserving therapies," said Michael Robinson, M.D., Vice President and Therapeutic Area Head, Ophthalmology, AbbVie. "We are excited to partner with Ripple to further advance the development of RTC-620."

Under terms of the agreement, Ripple will lead preclinical development of RTC-620. Upon exercise of the option, AbbVie will lead the clinical and commercialization activities. Ripple will receive an upfront payment of $21.8 million from AbbVie and is eligible to receive up to $290 million in aggregate option fees and milestones, as well as tiered royalties on net sales.

About Ripple Therapeutics

Ripple Therapeutics Corporation is a privately held clinical stage company focused on improving ophthalmic therapeutics with controllable sustained delivery implants without the use of polymers or excipients. Our novel therapeutics provide better outcomes for patients, easier management of care for physicians and lower cost for payors.

Piper Sandler acted as the exclusive financial advisor to Ripple.

For further information:

Media: Julie Fotheringham, [email protected], 416-951-7988

SOURCE: Ripple Therapeutics

海量资讯、精准解读,尽在新浪财经APP

扫描二维码推送至手机访问。

版权声明:本文由清远中大创新发布,如需转载请注明出处。

本文链接:http://idrdc.com/post/278.html

分享给朋友:

“Ripple Therapeutics宣布与艾伯维公司达成合作和许可选择协议,共同开发下一代青光眼治疗方案” 的相关文章

A股临近2700点 保卫战

A股临近2700点 保卫战

炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会!来源:北京商报9月9日,A股的市场行情引发市场极大关注,当日三大股指集体低开,上证综指最终收跌1.06%,报2736.49点,创今年2月6日以来新低。深证成指收跌0.83%,创业板指则尾盘拉升翻红,收涨0.06%。当日,A股多只...

大众汽车6家德国工厂或从明年6月开始裁员

大众汽车6家德国工厂或从明年6月开始裁员

盖世汽车讯 据报道,大众汽车将废除一系列劳工协议,其中包括6家德国工厂持续到2029年的就业保障协议。此举提高了这些工厂从明年开始裁员的可能性,而工人代表已发誓要抵制裁员。9月10日,大众汽车人力资源主管Gunnar Kilian在一份声明中表示,这些举措旨在“将该公司在德国的成本降至具有竞争力的水...

淘宝开放微信支付,今日生效!

淘宝开放微信支付,今日生效!

公示7天后,淘宝网新增的微信支付能力在今日逐步向所有淘宝网卖家开放。淘宝曾于9月初公告计划新增微信支付能力,允许商户接入微信支付方式。彼时公告显示,基于上述服务的增加,淘宝网相应升级平台规则,主要变化为:支付服务商相关的名称、账户、余额、交易额等表述统一规范为“支付机构”“支付账户”“支付账户余额”...

太突然,莱瑞金钰珠宝人去楼空!负责人失联!卷走超千万元

太突然,莱瑞金钰珠宝人去楼空!负责人失联!卷走超千万元

炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会!每年有8%~15%的利息,黄金托管享收益?又一家连锁金店人去楼空!有消费者称投了300万元……福州莱瑞金钰珠宝(王庄店)大门紧闭据《海峡都市报》报道,位于福州的连锁金店莱瑞金钰(珠宝)爆雷,其在福州的8家门店突然关闭,总负责人也...

王毅会见伊朗最高国家安全委员会秘书艾哈迈迪安

王毅会见伊朗最高国家安全委员会秘书艾哈迈迪安

9月12日,中共中央政治局委员、中央外办主任王毅在圣彼得堡会见伊朗最高国家安全委员会秘书艾哈迈迪安。王毅说,中伊关系历经国际风云考验,奠定坚实基础。中方赞赏伊朗新政府重申将坚持对华友好,愿继续巩固深化伊中关系。中方始终从战略高度和长远角度看待中伊关系,支持伊朗维护国家主权安全和民族尊严,走出符合自身...

启迪环境研究院:“构建全面创新体制机制,实现产业深度转型升级”系列报道之创新力量篇

启迪环境研究院:“构建全面创新体制机制,实现产业深度转型升级”系列报道之创新力量篇

炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会!一、国重技术转化新质生产力赋能产业高质量发展新格局近日,由启迪环境研究院承担技术服务的山西省孝义市餐厨垃圾制备生物质碳源项目开工建设。这是继今年6月份启迪环境研究院完成为期四年的国家重点研发计划“固废资源化”专项课题“城镇湿垃圾...

发表评论

访客

◎欢迎参与讨论,请在这里发表您的看法和观点。